792913-83-8 Usage
General Description
"Carbamic acid, (4-hydroxy-1-methylcyclohexyl)-, 1,1-dimethylethyl ester (9CI)" is a specific chemical compound with a complex structure. This type of carbamic acid borrows properties from its primary elements namely carbon, hydrogen, nitrogen, and oxygen. It also contains a cyclohexyl group, which is a functional group consisting of a ring of six carbon atoms, and a hydroxy group, which is a pair of hydrogen and oxygen atoms. The 1,1-dimethylethyl ester portion of the name indicates that this compound is an ester, which is an organic compound produced by the reaction of an alcohol and an acid. The "9CI" in its name implies it has been indexed in the 9th Collective Index of the Chemical Abstract Service (CAS). It is useful in various chemical reactions and processes in the field of chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 792913-83-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,2,9,1 and 3 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 792913-83:
(8*7)+(7*9)+(6*2)+(5*9)+(4*1)+(3*3)+(2*8)+(1*3)=208
208 % 10 = 8
So 792913-83-8 is a valid CAS Registry Number.
792913-83-8Relevant articles and documents
INHIBITORS OF RAF KINASES
-
Paragraph 00461-00463, (2021/04/30)
Provided herein are inhibitors of receptor tyrosine kinase effector, RAF, pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
2-CYANOPYRROLIDINE DERIVATIVES AND THEIR USE AS DPP-IV INHIBITORS
-
Page 30, (2010/02/09)
A compound of the formula (I) or a pharmaceutically acceptable salt thereof: [wherein X is CFH, or CF?2#191, R?1? is the moiety represented by the formula: [wherein R?2? is (lower) alkyl, R?3? is phenyl-(lower)alkyl, and the like.], and the like.] Compounds of formula (I) inhibit DPP-IV activity. They are therefore useful in the treatment of conditions mediated by DPP-IV, such as NIDDM.